PL425597A1 - Nowe związki peptydowe jako czynniki stymulujące gojenie ran i rekonstrukcji skóry - Google Patents
Nowe związki peptydowe jako czynniki stymulujące gojenie ran i rekonstrukcji skóryInfo
- Publication number
- PL425597A1 PL425597A1 PL42559718A PL42559718A PL425597A1 PL 425597 A1 PL425597 A1 PL 425597A1 PL 42559718 A PL42559718 A PL 42559718A PL 42559718 A PL42559718 A PL 42559718A PL 425597 A1 PL425597 A1 PL 425597A1
- Authority
- PL
- Poland
- Prior art keywords
- amino acid
- skin
- wounds
- reconstruction
- peptide compounds
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 5
- 206010052428 Wound Diseases 0.000 title 1
- 208000027418 Wounds and injury Diseases 0.000 title 1
- 230000035876 healing Effects 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 230000004936 stimulating effect Effects 0.000 title 1
- 150000001413 amino acids Chemical class 0.000 abstract 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 abstract 2
- 239000004471 Glycine Substances 0.000 abstract 1
- 102000016387 Pancreatic elastase Human genes 0.000 abstract 1
- 108010067372 Pancreatic elastase Proteins 0.000 abstract 1
- 206010072170 Skin wound Diseases 0.000 abstract 1
- 230000001133 acceleration Effects 0.000 abstract 1
- 230000002378 acidificating effect Effects 0.000 abstract 1
- 230000002209 hydrophobic effect Effects 0.000 abstract 1
- 230000003448 neutrophilic effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000029663 wound healing Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/52—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dispersion Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Materials For Medical Uses (AREA)
Abstract
Przedmiotem zgłoszenia są nowe związki o wzorze ogólnym: (R)n-(G)3,-B-(G)3-O-NH2, gdzie: R- oznacza XYZY, ZYXY, YZYX, YXYZ, n jest liczbą całkowitą (n < 50), X oznacza aminokwas kwasowy, Y oznacza aminokwas hydrofobowy, Z oznacza aminokwas zasadowy, B oznacza sekwencje specyficzną dla elastazy neutrofilowej, G oznacza aminokwas o nazwie glicyna, O oznacza sekwencję aktywną biologicznie w zakresie przyspieszenia gojenia ran skóry. Przedmiotem zgłoszenia jest ponadto sposób otrzymywania powyższych związków, sposób ich żelowania, kompozycja farmaceutyczna zawierająca nowy związek o wzorze ogólnym, a także zastosowanie powyższych nowych związków.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL425597A PL237001B1 (pl) | 2018-05-16 | 2018-05-16 | Nowy związek peptydowy jako czynnik stymulujący gojenie ran i rekonstrukcję skóry |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL425597A PL237001B1 (pl) | 2018-05-16 | 2018-05-16 | Nowy związek peptydowy jako czynnik stymulujący gojenie ran i rekonstrukcję skóry |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL425597A1 true PL425597A1 (pl) | 2019-11-18 |
| PL237001B1 PL237001B1 (pl) | 2021-03-08 |
Family
ID=68536639
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL425597A PL237001B1 (pl) | 2018-05-16 | 2018-05-16 | Nowy związek peptydowy jako czynnik stymulujący gojenie ran i rekonstrukcję skóry |
Country Status (1)
| Country | Link |
|---|---|
| PL (1) | PL237001B1 (pl) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL452111A1 (pl) * | 2024-05-21 | 2025-11-24 | Uniwersytet Gdański | Kompozycja hydrożelu regeneracyjnego do leczeniu ran |
| PL449964A1 (pl) | 2024-10-07 | 2026-04-13 | Gdański Uniwersytet Medyczny | Kompozycja farmaceutyczna o działaniu ochronnym i proregeneracyjnym oraz jej zastosowanie |
-
2018
- 2018-05-16 PL PL425597A patent/PL237001B1/pl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL237001B1 (pl) | 2021-03-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0512397A (pt) | composto,produto farmacêutico, métodos para suprimir a metástase de cáncer ou o crescimento do cáncer, para prevenir ou tratar uma doença ou condição, para controlar a função placentária, para melhorar a função gonadal, para induzir ou estimular a ovulação, para promover a secreção do hormÈnio gonadotrópico ou promover a secreção do hormÈnio sexual, para suprimir a secreção do hormÈnio gonadotrópico ou suprimir a secreção do hormÈnio sexual, para infra regular hormÈnio gonadrotópico ou hormÈnio sexual, e a proteìna ot7t175 humana, e para realçar a estabilidade no sangue, uso do composto, e, agente para suprimir a secreção do hormÈnio gonadotrópico ou um agente para suprimir a secreção do hormÈnio sexual | |
| PE20040942A1 (es) | Preparacion y tratamiento para las enfermedades desmielinizantes y paralisis mediante la aplicacion de agentes remielinizantes | |
| CY1112200T1 (el) | Συνδυασμοι για τη θεραπεια ασθενειων που ενεχουν κυτταρικο πολλαπλασιασμο | |
| BR0110703A (pt) | Amida, composição farmacêutica que compreende um composto, compostos, utilização de compostos, processos para o tratamento profilático ou terapêutico de diabetes do tipo ii e para a preparação desses compostos | |
| BR0316402A (pt) | vesìcula fusogênica, métodos para preparar uma vesìcula fusogênica encapsulante, e para encapsular pelo menos uma substáncia terapêutica ou imunologicamente ativa em uma vesìcula fusogênica, uso de uma vesìcula fusogênica, e, formulação farmacêutica | |
| UA104677C2 (ru) | Производные мочевины и их терапевтическое применение при лечении, среди прочего, заболеваний дыхательных путей | |
| CY1124916T1 (el) | Υγρο σκευασμα νευροτοξινης σταθεροποιημενο με τρυπτοφανη ή τυροσινη | |
| RU2010144637A (ru) | Замещенные гамма-лактамы в качестве терапевтических агентов | |
| AR003427A1 (es) | Péptidos relacionados con dolastatina, procedimiento para prepararlos, composiciones farmacéuticas que los contienen y el uso de los mismos para la preparación de dichas composiciones farmacéuticas. | |
| HRP20050544A2 (en) | Solid drug for oral use | |
| EA200100905A1 (ru) | Фармацевтическая композиция, содержащая ингибиторы протонного насоса | |
| CY1109843T1 (el) | Αναλογα της βιταμινης d | |
| EA200500528A1 (ru) | Пиперазинил- и диазапанилбензамиды и бензтиоамиды | |
| DE602004013993D1 (de) | R für biologische wirksubstanz zur oralen verabreichung | |
| PL425597A1 (pl) | Nowe związki peptydowe jako czynniki stymulujące gojenie ran i rekonstrukcji skóry | |
| EA202091318A1 (ru) | Препарат, содержащий аденовирус группы b | |
| EA200601846A1 (ru) | Содержащие бензоксазины лекарственные комбинации для лечения заболеваний дыхательных путей | |
| EA200802229A1 (ru) | Фармацевтическая композиция для лечения ожогов (варианты) и способ ее получения (варианты) | |
| EA202190261A1 (ru) | Топические маслянистые композиции | |
| EA202192925A1 (ru) | Твердые формы ингибитора glyt1 | |
| CY1120892T1 (el) | Σκευασματα δοσολογιας τροποποιητη υποδοχεα οπιοειδων | |
| EA202190310A1 (ru) | Белок для лечения воспалительных заболеваний | |
| MX2023014015A (es) | Formulación aminoácidica hidratante y método de uso. | |
| MX2024012582A (es) | Composiciones farmaceuticas de proteinas terapeuticas y metodos de uso | |
| BR112022005182A2 (pt) | Composto de amida heterocíclico, sal farmaceuticamente aceitável do mesmo, e método de preparação do mesmo e uso do mesmo |